MONOTHERAPY AND FIRST LINE USE ARE ASSOCIATED WITH HIGHER JAK-INHIBITOR RETENTION RATES IN PATIENTS IN BOTH RHEUMATOID AND PSORIATIC ARTHRITIS: A RETROSPECTIVE REAL-WORLD STUDY

被引：0
|
作者：
Luciano, N. [1 ]
Barone, E. [2 ,3 ]
Brunetta, E. [2 ,3 ]
De Santis, M. [2 ,3 ]
Ceribelli, A. [2 ,3 ]
Caprioli, M. [1 ]
Guidelli, G. M. [1 ]
Sonaglia, A. [1 ]
Renna, D. [1 ]
Isailovic, N. [2 ,3 ]
Selmi, C. [2 ,3 ]
机构：
[1] IRCCS Humanitas Res Hosp, Rheumatol & Clin Immunol, Milan, Rozzano, Italy
[2] IRCCS Humanitas Res Hosp, Milan, Rozzano, Italy
[3] Humanitas Univ, Rheumatol & Clin Immunol, Milan, Rozzano, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Psoriatic arthritis; Rheumatoid arthritis; Targeted synthetic drugs;
D O I：
10.1136/annrheumdis-2023-eular.4140
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0856
引用
收藏
页码：732 / 732
页数：1
相关论文
共 50 条
  • [1] Real-world retention rates of biologics in patients with rheumatoid arthritis
    Takami, Kenji
    Tsuji, Shigeyoshi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [2] Real-world retention rates of biologics in patients with rheumatoid arthritis
    Kenji Takami
    Shigeyoshi Tsuji
    Scientific Reports, 13
  • [3] Factors Associated with TNF Switching: a Retrospective Real-World Study of Patients with Rheumatoid Arthritis
    Wei, Wenhui
    Knapp, Keith
    Wang, Li
    Chen, Chieh-I
    Craig, Gary
    Ferguson, Karen
    Schwartzman, Sergio
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] Secukinumab after first-line tumor necrosis factor-alpha inhibitor therapy in psoriatic arthritis: A real-world retrospective cohort study
    Ak, Tumay
    Mustafayeva, Leyla
    Ayla, Ali Yagiz
    Celik, Yeliz
    Can, Gunay
    Ugurlu, Serdal
    ARCHIVES OF RHEUMATOLOGY, 2024, 39 (01) : 71 - 80
  • [5] Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study
    Claudia Grellmann
    Wojciech Dombrowsky
    Volker Fabricius
    Robert Suruki
    Anna Sheahan
    Lars Joeres
    Advances in Therapy, 2021, 38 : 366 - 385
  • [6] Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study
    Grellmann, Claudia
    Dombrowsky, Wojciech
    Fabricius, Volker
    Suruki, Robert
    Sheahan, Anna
    Joeres, Lars
    ADVANCES IN THERAPY, 2021, 38 (01) : 366 - 385
  • [7] Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment Retention
    Pope, Janet
    Finckh, Axel
    Silva-Fernandez, Lucia
    Mandl, Peter
    Fan, Haiyun
    Rivas, Jose L.
    Valderrama, Monica
    Montoro, Maria
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2024, 16 : 115 - 126
  • [8] A Multicenter, Real-world Clinical Data Study of the Use of JAK Kinase Inhibitors in a Large Cohort of Patients with Rheumatoid Arthritis
    Lopez-Lasanta, Maria
    Borrell, Helena
    Salles Lizarzaburu, Meritxell
    Ruiz-Esquide, Virginia
    Roig, Daniel
    Nack, Annika
    Perez, Carolina
    Bernardez, Julia
    Garcia, Andrea
    Rovira, Joana
    Cuervo, Andrea
    Valls, Marta
    Garcia, Carmen
    Minguez, Sonia
    Morla, Rosa
    Estrada, Paula
    Martinez, Melania
    Pitarch, Conxita
    Busquets, Noemi
    Park, Hye
    Gomez-Puerta, Jose A.
    Holgado, Susana
    Montala, Nuria
    Sanmarti, Raimon
    Mateo, Lourdes
    Diaz, Cesar
    Corominas, Hector
    Salvador, Georgina
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 833 - 836
  • [9] Pattern of drug use in patients with psoriatic arthritis in Italy: study in a real-world setting
    Perrone, Valentina
    Losi, Serena
    Filippi, Erica
    Sangiorgi, Diego
    Degli Esposti, Luca
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (04) : 721 - 727
  • [10] ABATACEPT RETENTION RATES AND PROGNOSTIC FACTORS OF RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS: 2-YEAR RESULTS FROM THE REAL-WORLD ACTION STUDY
    Alten, R.
    Lorenz, H-M.
    Mariette, X.
    Nuesslein, H.
    Galeazzi, M.
    Navarro, F.
    Chartier, M.
    Elbez, Y.
    Rauch, C.
    Le Bars, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 577 - 578
12345